Source comparison
AOD-9604 Results After 1 Month: Clinical vs Anecdotal Comparison
Body Fat % (DEXA) 1.2–2.8% reduction from baseline Not measured. Users rely on visual assessment DEXA or Bod Pod required for accuracy; calipers introduce 3–5% error margin Scale Weight Change 1.5–3.2 lbs average loss 0–4 lbs reported; high variance due to wat
This comparison does not assign a generated winner or score.
- Body Fat % (DEXA)
- 1.2–2.8% reduction from baseline
- Not measured. Users rely on visual assessment
- DEXA or Bod Pod required for accuracy; calipers introduce 3–5% error margin
- Scale Weight Change
- 1.5–3.2 lbs average loss
- 0–4 lbs reported; high variance due to water retention
- Scale weight alone is insufficient. Simultaneous lean mass gain masks fat loss
- Waist Circumference (cm)
- 1.1–2.3 cm average reduction
- 1–3 cm self-reported; measurement inconsistency common
- Measure at navel, same time daily, empty stomach. Improves reliability
- Subjective Visual Change
- Not assessed in trials
- 60–70% report "tighter midsection" by week 3–4
- Real but non-quantitative; lighting and posture affect perception
- Adverse Events
- Mild injection-site irritation in 12%; no metabolic disruption
- Occasional headache or fatigue in first week; resolves spontaneously
- Fragment lacks GH's insulin-resistance effects. Metabolic safety profile is clean